<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=118459&amp;fmt=gif">
Show all

COVID-19 Vaccine Coverage and Premium Discount FAQs

COVID-19 Vaccine Coverage and Premium Discount FAQs

1.5 minute read

The Departments of Labor, Health and Human Services, and the Treasury issued FAQs addressing rules regarding premium incentives for COVID-19 vaccinations and rapid coverage of preventive services for COVID-19.

Premium discounts for COVID-19 vaccination typically must be offered as part of a wellness program. These wellness programs will generally be required to offer a reasonable alternative standard to qualify for the discount for certain individuals. Plans usually may not condition eligibility for benefits or coverage on vaccination status, and any discount must comply with the final wellness program rules.

According to the FAQs, plans and issuers must cover, without cost sharing, any COVID-19 vaccines and their administration once the vaccine becomes authorized under an emergency use authorization or approved under a biologics license application. This includes to allow for an additional dose to certain individuals, boosters doses, or the expansion of the age demographic for whom the vaccine is authorized or approved.

Download the bulletin for more details.

New call-to-action

This blog is intended to be a compilation of information and resources pulled from federal, state, and local agencies. This is not intended to be legal advice. For up to the minute information and guidance on COVID-19, please follow the guidelines of the Centers for Disease Control and Prevention (CDC) and your local health organizations.

National Insurance Services is not a law firm and no opinion, suggestion, or recommendation of the firm or its employees shall constitute legal advice. Readers are advised to consult with their own attorney for a determination of their legal rights, responsibilities and liabilities, including the interpretation of any statute or regulation, or its application to the readers’ business activities.

FDA Authorizes COVID-19 At-home Rapid Test
October 18, 2021
COVID-19 Vaccine Mandate for Eligible California Students
October 18, 2021
Erin Woulfe

Erin Woulfe

Erin Woulfe likes to write about things that matter. Keeping her finger on the pulse of what’s happening in the public sector world, she blogs about the latest legislative news and employee benefit trends that affect our school, city and county clients. She’s been with NIS since 2002. “I love connecting to our clients and providing them with the tools they need in order to administrate their plan,” says Erin. “Whether that be materials to educate their employees on certain benefits, how to effectively communicate change within an organization, or providing tips and how-to’s to help them make their job easier.”